Literature DB >> 20705903

Role of cholinergic neurons in the motor effects of glucagon-like peptide-2 in mouse colon.

Antonella Amato1, Alessandra Rotondo, Lorenzo Cinci, Sara Baldassano, Maria Giuliana Vannucchi, Flavia Mulè.   

Abstract

Glucagon-like peptide-2 (GLP-2) reduces mouse gastric tone and small intestine transit, but its action on large intestine motility is still unknown. The purposes of the present study were 1) to examine the influence of GLP-2 on spontaneous mechanical activity and on neurally evoked responses, by recording intraluminal pressure from mouse isolated colonic segments; 2) to characterize GLP-2 mechanism of action; and 3) to determine the distribution of GLP-2 receptor (GLP-2R) in the mouse colonic muscle coat by immunohistochemistry. Exogenous GLP-2 (0.1-300 nM) induced a concentration-dependent reduction of the spontaneous mechanical activity, which was abolished by the desensitization of GLP-2 receptor or by tetrodotoxin, a voltage-dependent Na(+)-channel blocker. GLP-2 inhibitory effect was not affected by N(ω)-nitro-l-arginine methyl ester (a nitric oxide synthase inhibitor), apamin (a blocker of small conductance Ca(2+)-dependent K(+) channels), or [Lys1,Pro2,5,Arg3,4,Tyr6]VIP(7-28) (a VIP receptor antagonist), but it was prevented by atropine or pertussis toxin (PTX), a G(i/o) protein inhibitor. Proximal colon responses to electrical field stimulation were characterized by nitrergic relaxation, which was followed by cholinergic contraction. GLP-2 reduced only the cholinergic evoked contractions. This effect was almost abolished by GLP-2 receptor desensitization or PTX. GLP-2 failed to affect the contractile responses to exogenous carbachol. GLP-2R immunoreactivity (IR) was detected only in the neuronal cells of both plexuses of the colonic muscle coat. More than 50% of myenteric GLP-2R-IR neurons shared the choline acetyltransferase IR. In conclusion, the activation of GLP-2R located on cholinergic neurons may modulate negatively the colonic spontaneous and electrically evoked contractions through inhibition of acetylcholine release. The effect is mediated by G(i) protein.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20705903     DOI: 10.1152/ajpgi.00282.2010

Source DB:  PubMed          Journal:  Am J Physiol Gastrointest Liver Physiol        ISSN: 0193-1857            Impact factor:   4.052


  9 in total

1.  GLP-2 receptor in POMC neurons suppresses feeding behavior and gastric motility.

Authors:  Xinfu Guan; Xuemei Shi; Xiaojie Li; Benny Chang; Yi Wang; Depei Li; Lawrence Chan
Journal:  Am J Physiol Endocrinol Metab       Date:  2012-07-24       Impact factor: 4.310

Review 2.  The CNS glucagon-like peptide-2 receptor in the control of energy balance and glucose homeostasis.

Authors:  Xinfu Guan
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2014-07-02       Impact factor: 3.619

3.  Regulation of mouse intestinal L cell progenitors proliferation by the glucagon family of peptides.

Authors:  Marine Grigoryan; Mamdouh H Kedees; Maureen J Charron; Yelena Guz; Gladys Teitelman
Journal:  Endocrinology       Date:  2012-05-08       Impact factor: 4.736

4.  Glucagon-like peptide-2 treatment improves glucose dysmetabolism in mice fed a high-fat diet.

Authors:  Sara Baldassano; Antonella Amato; Gaetano Felice Caldara; Flavia Mulè
Journal:  Endocrine       Date:  2016-01-30       Impact factor: 3.633

5.  Glucagon-like peptide-2 modulates the nitrergic neurotransmission in strips from the mouse gastric fundus.

Authors:  Rachele Garella; Eglantina Idrizaj; Chiara Traini; Roberta Squecco; Maria Giuliana Vannucchi; Maria Caterina Baccari
Journal:  World J Gastroenterol       Date:  2017-10-28       Impact factor: 5.742

6.  Effects of exogenous glucagon-like peptide-2 and distal bowel resection on intestinal and systemic adaptive responses in rats.

Authors:  Sarah W Lai; Elaine de Heuvel; Laurie E Wallace; Bolette Hartmann; Jens J Holst; Mary E Brindle; Prasanth K Chelikani; David L Sigalet
Journal:  PLoS One       Date:  2017-07-24       Impact factor: 3.240

7.  Increased Body Weight and Fat Mass After Subchronic GIP Receptor Antagonist, but Not GLP-2 Receptor Antagonist, Administration in Rats.

Authors:  Sara Baldassano; Lærke Smidt Gasbjerg; Hüsün Sheyma Kizilkaya; Mette Marie Rosenkilde; Jens Juul Holst; Bolette Hartmann
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-06       Impact factor: 5.555

8.  Glucagon-Like Peptide 2 Inhibits Postprandial Gallbladder Emptying in Man: A Randomized, Double-Blinded, Crossover Study.

Authors:  Nina L Hansen; Andreas Brønden; Christina C Nexøe-Larsen; Alexander S Christensen; David P Sonne; Jens F Rehfeld; Nicolai J Wever Albretchsen; Bolette Hartmann; Tina Vilsbøll; Jens J Holst; Filip K Knop
Journal:  Clin Transl Gastroenterol       Date:  2020-12       Impact factor: 4.396

9.  GLP-2 Prevents Neuronal and Glial Changes in the Distal Colon of Mice Chronically Treated with Cisplatin.

Authors:  Patrizia Nardini; Alessandro Pini; Anne Bessard; Emilie Duchalais; Elena Niccolai; Michel Neunlist; Maria Giuliana Vannucchi
Journal:  Int J Mol Sci       Date:  2020-11-23       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.